GeneDx
Highly Engaged Employees
Highly Engaged EmployeesHealthcare Services · Connecticut, United States · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
333 Ludlow St Ste 6, Stamford, Connectic...Phone Number
(301) 519-2100Website
www.genedx.comRevenue
$442.7 MillionStock Symbol
WGSIndustry
ZI Rank: 13
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
18
13
16
14
22
13
About GeneDx
GeneDx, Inc. is a commercial-stage genomic diagnostics company founded in 2000 and headquartered in Stamford, Connecticut, with its laboratory operations based in Gaithersburg, Maryland. The company specializes in genetic testing for the diagnosis of rare and inherited disorders, offering whole exome sequencing, whole genome sequencing, and targeted gene panels to healthcare providers and hospitals. GeneDx operates one of the world's largest rare disease genomic datasets, which powers its clinical testing capabilities and supports drug discovery and health system research. The company also provides genetic counseling services and financial assistance programs to support patient access to testing.Explore more
GeneDx Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is GeneDx your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when GeneDx launches new products
GeneDx, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if GeneDx is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at GeneDx
Earning: See what the market has to say on GeneDx recently announced quarterly report
Check if GeneDx has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if GeneDx had a recent Job posting/layoffs
Funding: Get notified immidiatlly once GeneDx has new funding data
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to GeneDx
Compare insights from companies similar to GeneDx, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
GeneDx is experiencing low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
GeneDx is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about GeneDx.
GeneDx Tech Stack
A closer look at the technologies used by GeneDx
Most Recent Scoops
Open Position
Person-Based
Earnings, Finance
Open Position
Hiring Plans
GeneDx has more open roles in Finance than it has had at any time in the past 12 months.
Hiring Plans
Person-Based
Earnings, Finance
GeneDx News & Media
GeneDx Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against GeneDx Holdings Corp. - WGS
NEW ORLEANS, June 12, 2026 /PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until August 3, 2026 to file lead plaintiff applications in a securities class action lawsuit against GeneDx Holdings Corp. (NasdaqGS: WGS), if they purchased...WGS INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds GeneDx (WGS) Investors of Securities Class Action Lawsuit Deadline on August 3, 2026
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In GeneDx To Contact Him Directly To Discuss Their OptionsROSEN, TOP RANKED INVESTOR COUNSEL, Encourages GeneDx Holdings Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action - WGS
NEW YORK, June 11, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of GeneDx Holdings Corp. (NASDAQ: WGS) between April 16, 2025 and May 4, 2026, inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 3, 2026.WGS Class Action Notice: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the GeneDx Holdings Corp. Class Action Lawsuit
Robbins LLP is Investigating Allegations that GeneDx Holdings Corp. (WGS) Misled Investors Regarding the Positive Impact of the Fabric Genomics Acquisition
Read more news
Top Healthcare Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding GeneDx
Sign Up For FreeTo access detailed company insights
GeneDx, Inc. is a commercial-stage genomic diagnostics company founded in 2000 and headquartered in Stamford, Connecticut, with its laboratory operations based in Gaithersburg, Maryland. The company specializes in genetic testing for the diagnosis of rare and inherited disorders, offering whole exome sequencing, whole genome sequencing, and targete... Read More
